fluid sepsis ny_2013a

95
Fluid in Sepsis: A New Paradigm Paul Marik, MD, FCCP, FCCM

Upload: emcrit-blog-and-podcast

Post on 28-Nov-2014

706 views

Category:

Health & Medicine


3 download

DESCRIPTION

Marik's fluid slides

TRANSCRIPT

Page 1: Fluid sepsis ny_2013a

Fluid in Sepsis: A New ParadigmPaul Marik, MD, FCCP, FCCM

Page 2: Fluid sepsis ny_2013a

Disclosures

Stocks

Advisory boards

Grants

Speakers Bureau

None

Page 3: Fluid sepsis ny_2013a

Scientific Disclosures

Three Great Myths in the management of

sepsis

Sepsis is associated with tissue hypoxia

Protocols to “optimize” CI or DO2 improve

outcome

Sepsis is “volume depleted” state

Page 4: Fluid sepsis ny_2013a

JAMA 1992;267:1503

Page 5: Fluid sepsis ny_2013a

Ronco JJ, et al. JAMA 1993;270:1724

4ml/kg/min

Page 6: Fluid sepsis ny_2013a
Page 7: Fluid sepsis ny_2013a

N Engl J Med 1994; 330:1717

Page 8: Fluid sepsis ny_2013a

From: Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in

Patients With Septic Shock: A Randomized Clinical Trial

JAMA. 2013;():-. doi:10.1001/jama.2013.278477

0

100

200

300

400

500

600

BL 24 hr 48 hr 72 hr

DO2

Esmolol Control

Page 9: Fluid sepsis ny_2013a

From: Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in

Patients With Septic Shock: A Randomized Clinical Trial

JAMA. 2013;():-. doi:10.1001/jama.2013.278477

Time Hrs

0 20 40 60 80 100 120

0

100

200

400

500

600

La

cta

te

1.0

1.5

2.0

2.5

3.0

Time vs Lactate - E

Time vs Lactate - C

DO2/VO2

DO2

Page 10: Fluid sepsis ny_2013a

From: Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in

Patients With Septic Shock: A Randomized Clinical Trial

JAMA. 2013;():-. doi:10.1001/jama.2013.278477

Page 11: Fluid sepsis ny_2013a
Page 12: Fluid sepsis ny_2013a
Page 13: Fluid sepsis ny_2013a

Oxygen kinetics in sepsis

Oxygen requirement are not increased in patients

with sepsis

An oxygen debt does not exist in patients with

sepsis

Lactate is produced aerobically as part of the stress

response

Attempts to increase DO2 in response to an

elevated lactate is

Illogical and devoid of scientific evidence

Likely to be harmful

Page 14: Fluid sepsis ny_2013a

Historical Perspective

Page 15: Fluid sepsis ny_2013a

Lancet, Feb 4 1882

Page 16: Fluid sepsis ny_2013a
Page 17: Fluid sepsis ny_2013a
Page 18: Fluid sepsis ny_2013a

His first patient was an elderly women who had reached

the last moments of her earthly existence. “Having no

precedent to guide me I proceeded with much caution”

Page 19: Fluid sepsis ny_2013a

His first patient was an elderly women who had reached

the last moments of her earthly existence. “Having no

precedent to guide me I proceeded with much caution”

Latta inserted a tube into the basilic vein and injected

ounce after ounce of fluid, closely observing the patient.

Page 20: Fluid sepsis ny_2013a

His first patient was an elderly women who had reached

the last moments of her earthly existence. “Having no

precedent to guide me I proceeded with much caution”

Latta inserted a tube into the basilic vein and injected

ounce after ounce of fluid, closely observing the patient.

“the sunken eyes and fallen jaw, pale and cold extremities

bearing the manifest imprint of deaths signet, began to

glow with returning animation; the pulse returned to the

wrist”

Page 21: Fluid sepsis ny_2013a

From this to …. The “Rivers” Protocol

Page 22: Fluid sepsis ny_2013a

Goals of Hemodynamic Resuscitation

Achieve an adequate perfusion pressure

MAP > 65 mmHg

Improve microcirculatory flow

Limit tissue edema

Page 23: Fluid sepsis ny_2013a
Page 24: Fluid sepsis ny_2013a

Crit Care Med 2013; 41:34

Page 25: Fluid sepsis ny_2013a

The Hemodynamic derangements of sepsis

Vasoplegic shock/vasodilatory shock

Nitric oxide

ANP

KATP

Vasopressin

Leaky capillaries

Glycocalyx

Endothelial junctions

Myocardial depression

Nitric Oxide

Page 26: Fluid sepsis ny_2013a
Page 27: Fluid sepsis ny_2013a

1. NO/ANP

Page 28: Fluid sepsis ny_2013a

2. Activation of KATP

Page 29: Fluid sepsis ny_2013a

3. Vasopressin deficiency

Page 30: Fluid sepsis ny_2013a

VGEF

Angiopoeitin 2

Page 31: Fluid sepsis ny_2013a

Starling Principle

Starling (1896) states fluid exchange is governed by

high vascular COP and low interstitial COP

Recently it is proved that intravascular COP is

almost identical to extravascular one

Jacob M. et al Cardiovascular Research 2007; 73:

575-586

Page 32: Fluid sepsis ny_2013a

EG consists of membrane-bound proteoglycans and glycoproteins network in which plasma or endothelial proteins are retained - forms the endothelial surface layer (ESL)

ESL thickness is 1μm

Jacob M. et al Cardiovascular Research 2007; 73:

575-586

Endothelial Glycocalyx

Page 33: Fluid sepsis ny_2013a
Page 34: Fluid sepsis ny_2013a

The Glycocalyx Denuded in Sepsis

Page 35: Fluid sepsis ny_2013a
Page 36: Fluid sepsis ny_2013a

Crit Care Med 2008; 36:1701

Norepi 0.8 ug/kg/min Norepi 0.4 ug/kg/min

Dobutamine 5 ug/kg/minLVFAC= left ventricular fractional area contraction

Page 37: Fluid sepsis ny_2013a

The Hemodynamic derangements of sepsis

FLUIDS INCREASE Vasoplegic shock/vasodilatory shock

Nitric oxide

BNP

KATP

Vasopressin

FLUIDS INCREASE Leaky capillaries

Glycocalyx

Endothelial junctions

FLUIDS INCREASE Myocardial depression

Nitric Oxide

Myocardial edema

Page 38: Fluid sepsis ny_2013a

Fluid may not be the most efficient method to increase

MAP in septic shock

Page 39: Fluid sepsis ny_2013a

Crit Care Med 2007;35:477

% change in cardiac Index

Page 40: Fluid sepsis ny_2013a

Eur J Pharmacology 2009;621:67

Page 41: Fluid sepsis ny_2013a

BNP damages glycocalyx

Inc atrial pressure leads to a release of natriuretic

peptides

ANP/BNP shed off the glycocalyx components

(syndecan -1) into the circulation

This is accompanied by significant rapid shifts of

intravascular fluid into interstitial space

Bruegger D. et al Am J Physiol 2005; 289: H1993

Page 42: Fluid sepsis ny_2013a

Ueda S, et al. Shock 2006;26:123

Resuscitated according to EGDRx

0

200

400

600

800

1000

1200

1400

Admission Day 1 Day 2 Day 4

Survivors Non-survivors

BNP (pg/ml)

Page 43: Fluid sepsis ny_2013a
Page 44: Fluid sepsis ny_2013a
Page 45: Fluid sepsis ny_2013a

Bark BP, et al. Crit Care Med 2013;41

CLP

Page 46: Fluid sepsis ny_2013a

Excess fluid Increases mortality in

patients with sepsis

Page 47: Fluid sepsis ny_2013a

The Evidence: Experimental Models

Page 48: Fluid sepsis ny_2013a

Crit Care 2009; 13:R186

48 pigs randomized to endotoxin infusion, fecal peritonitis

or control

Each group randomized to Moderate (10ml/kg/hr) or High

volume-EGDRx (20 ml/kg/hr) LR resuscitation for 24 hrs

High Volume-EGDRx Group

Higher CI

Higher MAP

Higher PCWP

Lower lactate

Higher SmvO2

Page 49: Fluid sepsis ny_2013a

Crit Care 2009; 13:R186

Page 50: Fluid sepsis ny_2013a
Page 51: Fluid sepsis ny_2013a
Page 52: Fluid sepsis ny_2013a

The Evidence: Clinical Studies

Page 53: Fluid sepsis ny_2013a

Alsous F et al. Chest 2000;117:1749

Page 54: Fluid sepsis ny_2013a

The Soap Study

Crit Care Med 2006; 34:344

Page 55: Fluid sepsis ny_2013a

Crit Care Med 2011;39:256-265

Page 56: Fluid sepsis ny_2013a

Crit Care Med 2011;39:256-265

Optimal survival occurred with a

positive fluid balance of approximately

3 liters at 12 hours

Page 57: Fluid sepsis ny_2013a

Patients with CVP <8

mmHg at 12 hrs had

the lowest mortality.

Crit Care Med 2011;39:256-265

Page 58: Fluid sepsis ny_2013a
Page 59: Fluid sepsis ny_2013a

Days

Page 60: Fluid sepsis ny_2013a

Association of cumulative fluid balance on outcome

in ALI: A review of the ARDSnet cohort

J Intens Care Med 2009;24:35

Page 61: Fluid sepsis ny_2013a

2009; 136:102-109

Non-survivors

Survivors

Page 62: Fluid sepsis ny_2013a

Resp Med 2008;102:956

Page 63: Fluid sepsis ny_2013a

Mortality 48 hrs Mortality 4 weeks

Maitland K, et al. NEJM 2011; 364:2483

Page 64: Fluid sepsis ny_2013a
Page 65: Fluid sepsis ny_2013a
Page 66: Fluid sepsis ny_2013a
Page 67: Fluid sepsis ny_2013a

Fluid resuscitation in sepsis

“Give them as much as they need and

not a drop more”….

Page 68: Fluid sepsis ny_2013a

Where's the Blood Volume?

Page 69: Fluid sepsis ny_2013a
Page 70: Fluid sepsis ny_2013a

Crit Care Med 2012;40:3146

Before After

Dose norepinephrine

(ug/kg/min)0.3 0.19

CI (l/min/M2) 3.47 3.28

CI change by PLR (%) 1 8

Mean systemic pressure

(mmHg)33 26

GEDVI (ml/m2) 819 774

Page 71: Fluid sepsis ny_2013a

The lowest mortality was seen in patients with lower SOFA scores

and early norepinephrine administration after admission.

Conclusion: Both the time of starting norepinephrine after

admission to the

ICU and the degree of organ dysfunction have an important bearing

on subsequent

Outcome

Crit Care Med 2000;28:947

Page 72: Fluid sepsis ny_2013a

Geleon A, et al. Crit Care Med 2014 (ePub

Page 73: Fluid sepsis ny_2013a

Normal adrenal function

Impaired adrenal function

Before HC After HC

Annane, British Journal of Clinical Pharmacology, 1998

Effect of Hydrocortisone on Sepsis-Induced

Hypotension

Page 74: Fluid sepsis ny_2013a

SV

EVLW

Preload

Large increase in EVLW

Small increase in CO

The Frank-Starling & Marik-Phillips Curves

Large increase in CO

Small increase in EVLW

Sepsis

Page 75: Fluid sepsis ny_2013a

Techniques to Assess Fluid Responsiveness

Page 76: Fluid sepsis ny_2013a

Excellent

Fair-Good

Worthless

ROC Curves & Diagnostic Accuracy

Page 77: Fluid sepsis ny_2013a

Assessment of fluid

responsivenessTechnique

CVP/PAOP

IVC/SVC diameter

FTc (LVETc)

RVEDV/LVEDA/GEDI

IVC/SVC - respiratory variation

PPV/SVV/PVI

Aortic blood flow - respiratory

variation

Passive Leg Raising

(PLR)

Technology

CVP/PAC

Non calibrated pulse contour

Bioimpedance

Ultrasound (IVC/SVC)

Ultrasound (IVC/SVC resp. variability)

Pleth waveform (PVI)

ECHO- Aortic Doppler (resp. variability)

Calibrated pulse contour (PPV/SVV)

Esophageal Doppler (PLR &

volume)

Calibrated pulse contour (PLR &

volume)

Page 78: Fluid sepsis ny_2013a

Assessment of fluid responsiveness

Technique

PLR

Volume

Challenge

Technology

Esophageal Doppler

Calibrated pulse

contour

NICOM -

Bioreactance

Page 79: Fluid sepsis ny_2013a

Study name sample size AUC

Monnet CCM 2006 71 0.96

Lafanéchère CC 2006 22 0.95

Lamia ICM 2007 24 0.96

Maizel ICM 2007 34 0.89

Monnet CCM 2009 34 0.94

Thiel CC 2009 102 0.89

Biais CC 2009 30 0.96

Preau CCM 2010 34 0.94

351 0.95

Study name sample size AUC

Monnet CCM 2006 71 0.75

Monnet CCM 2009 34 0.68

Preau CCM 2010 34 0.86

139 0.76

PLR-induced changes in PP

Page 80: Fluid sepsis ny_2013a

Which Fluid?

Crystalloids

Balanced Salt Solutions (BSS)

Ringers

Plasmalyte

Un-physiologic Salt Solutions

(USS)

NaCl

Colloids

Albumin (USS)

Starches (USS)

Page 81: Fluid sepsis ny_2013a
Page 82: Fluid sepsis ny_2013a

Chloride liberal vs. Chloride Restrictive

Strategy

Page 83: Fluid sepsis ny_2013a

Anesth Analg 2013:117:412

Page 84: Fluid sepsis ny_2013a

“Ab-Normal” Saline vs. Balanced Salt

Solution Metabolic and dilutional acidosis

Decreased renal blood flow

Coagulopathy- more bleeding

Increased inflammation

Increased risk of renal failure

Increased risk of death

Page 85: Fluid sepsis ny_2013a

NEJM 2008;358:125

Page 86: Fluid sepsis ny_2013a
Page 87: Fluid sepsis ny_2013a

5% Albumin

Maintains endothelial glycocalyx and “endothelial

function”

Anti-oxidant properties

Anti-inflammatory properties

May limit “third” space loss

Albumin has a number of features that may be theoretically advantageous

in patients with sepsis and SIRS including:

Page 88: Fluid sepsis ny_2013a

Kozar R, et al. Anesth Analg

2011;112:1289

Page 89: Fluid sepsis ny_2013a

Pts. with severe sepsis or septic shock (6-24 hr)

Albumin Crystalloid

s

crystalloids

Albumin:

[300 ml at 20% in 3* hrs]

+

crystalloids

Study design

Randomization

Volume replacement

Study design

Page 90: Fluid sepsis ny_2013a

from day 1 to day 28

Plasma albumin

level

< 30 g/L

≥ 25 g/L≥ 30 g/L

No infusion

of Albumin

Infusion of

Albumin:

200 ml at 20%

in 3* hrs

< 25 g/L

Infusion of

Albumin:

300 ml at 20%

in 3* hrs

Albumin

Page 91: Fluid sepsis ny_2013a
Page 92: Fluid sepsis ny_2013a
Page 93: Fluid sepsis ny_2013a

Marik PE. Chest 2014 (in press)

Page 94: Fluid sepsis ny_2013a
Page 95: Fluid sepsis ny_2013a